U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Chou R, Cantor A, Dana T, et al. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: A Systematic Review for the U.S. Preventive Services Task Force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2022 Aug. (Evidence Synthesis, No. 219.)

Cover of Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: A Systematic Review for the U.S. Preventive Services Task Force

Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: A Systematic Review for the U.S. Preventive Services Task Force [Internet].

Show details

Table 1Statin Dosing and ACC/AHA Classification of Intensity

StatinLow-Intensity Dosage (LDL-C Reduction <30%)Moderate-Intensity Dosage (LDL-C Reduction 30% to <50%)High-Intensity Dosage (LDL-C Reduction ≥50%)
AtorvastatinNA10 to 20 mg40 to 80 mg
Fluvastatin20 to 40 mg40 mg 2x/day; XL 80 mgNA
Lovastatin20 mg40 to 80 mgNA
PitavastatinNA1 to 4 mgNA
Pravastatin10 to 20 mg40 to 80 mgNA
RosuvastatinNA5 to 10 mg20 to 40 mg
Simvastatin10 mg20 to 40 mgNA

From ACC/AHA, 2018.199 Dosages shown are total daily dosages; exceptions are noted.

Abbreviations: ACC=American College of Cardiology; AHA=American Heart Association; LDL-C=low-density lipoprotein cholesterol; NA=not applicable.

Views

  • Cite this Page
  • PDF version of this title (2.6M)

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...